142 related articles for article (PubMed ID: 24986680)
1. Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma.
Wenaas AE; Nagy CZ; Yiu Y; Xu L; Horter K; Zevallos JP
Head Neck; 2015 Dec; 37(12):1776-80. PubMed ID: 24986680
[TBL] [Abstract][Full Text] [Related]
2. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Intenzo CM; Willis AI
Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
[TBL] [Abstract][Full Text] [Related]
3. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes.
Tang J; Kong D; Cui Q; Wang K; Zhang D; Liao X; Gong Y; Wu G
World J Surg Oncol; 2018 Mar; 16(1):45. PubMed ID: 29506526
[TBL] [Abstract][Full Text] [Related]
5. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
[TBL] [Abstract][Full Text] [Related]
6. National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.
Chang EHE; Lutfi W; Feinglass J; Reiher AE; Moo-Young T; Bhayani MK
World J Surg; 2016 Dec; 40(12):2930-2940. PubMed ID: 27447700
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.
Pitoia F; Bueno F; Urciuoli C; Abelleira E; Cross G; Tuttle RM
Thyroid; 2013 Nov; 23(11):1401-7. PubMed ID: 23517313
[TBL] [Abstract][Full Text] [Related]
8. Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.
Hassan A; Razi M; Riaz S; Khalid M; Nawaz MK; Syed AA; Bashir H
Clin Nucl Med; 2016 Aug; 41(8):606-13. PubMed ID: 27124680
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic disparities in differentiated thyroid cancer survival among adolescents and young adults in California.
Keegan TH; Grogan RH; Parsons HM; Tao L; White MG; Onel K; Horn-Ross PL
Thyroid; 2015 Jun; 25(6):635-48. PubMed ID: 25778795
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
11. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
Zhao H; Gong Y
Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
[TBL] [Abstract][Full Text] [Related]
12. The overuse of radioactive iodine in low-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Willis AI
Surg Oncol; 2019 Jun; 29():184-189. PubMed ID: 31196486
[TBL] [Abstract][Full Text] [Related]
13. High suspicion US pattern on the ATA guidelines, not cytologic diagnosis, may be a predicting marker of lymph node metastasis in patients with classical papillary thyroid carcinoma.
Cho E; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Am J Surg; 2018 Sep; 216(3):562-566. PubMed ID: 29268941
[TBL] [Abstract][Full Text] [Related]
14. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in papillary thyroid microcarcinoma survival.
Megwalu UC; Saini AT
J Laryngol Otol; 2017 Jan; 131(1):83-87. PubMed ID: 27917722
[TBL] [Abstract][Full Text] [Related]
16. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies.
Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048
[TBL] [Abstract][Full Text] [Related]
17. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer.
Zevallos JP; Xu L; Yiu Y
Thyroid; 2014 Apr; 24(4):758-63. PubMed ID: 24378070
[TBL] [Abstract][Full Text] [Related]
18. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
19. Urban and Rural Surgical Practice Patterns for Papillary Thyroid Carcinoma.
Collins RA; Chaves N; Lee G; Broekhuis JM; James BC
Thyroid; 2023 Jul; 33(7):849-857. PubMed ID: 37014086
[No Abstract] [Full Text] [Related]
20. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
Du XL; Fang S; Coker AL; Sanderson M; Aragaki C; Cormier JN; Xing Y; Gor BJ; Chan W
Cancer; 2006 Mar; 106(6):1276-85. PubMed ID: 16475208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
